Skip to main content
. 2015 Jul 3;1(3):20150060. doi: 10.1259/bjrcr.20150060

Figure 2.

Figure 2.

A 45-year-old female post therapy for breast cancer. Axial positron emission tomography image (a) and coronal maximum intensity projection image (b) show interval development of symmetric hilar adenopathy with intermediateJ 18-fludeoxyglucose activity (arrows).